Search clinical trials for: Conversion

Total 1162 results

King's College London
University of Sheffield; University of Edinburgh; South London and Maudsley NHS... and other collaborators

Completed

Comparing Different Treatments in Reducing Dissociative Seizure Occurrence (CODES)

Conversion Disorder | Dissociative Disorder | Convulsion, Nonepileptic

United Kingdom
Sichuan Haisco Pharmaceutical Group Co., Ltd

Completed

A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on After Meals in Healthy Subjects

Healthy

China
Sichuan Haisco Pharmaceutical Group Co., Ltd

Completed

A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy Subjects

Healthy

China
Theranexus

Completed

Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients

Narcolepsy

France, Belgium
Novartis Pharmaceuticals

Completed

randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure (OUTSTEP-HF)

Chronic Heart Failure With Reduced Ejection Fraction

Belgium, Estonia, Denmark, Greece, United Kingdom, Germany, Latvia, Lithuania, Spain, Netherlands, Bulgaria, Finland, Poland, Czechia, Iceland, Sweden, France, Ireland, Norway
University of Wisconsin, Madison

Completed

Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's (SEAIRA)

Hypertension | Alzheimer's Disease

United States
Fudan University

Unknown

Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

Colorectal Cancer | Liver Metastases
University Children's Hospital Basel

Completed

Human Intestinal Amino Acid Absorption and the Role of a Local RAS

Renin-Angiotensin Aldosterone System (RAS)

Switzerland
Odense University Hospital
University of Southern Denmark; Alice Brenaa Foundation; Hede Nielsen Foundation and other collaborators

Terminated

Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors (KSDH)

Hematoma, Subdural, Chronic
University of British Columbia
University of Pennsylvania; Wuhan University; Canadian Institutes of Health Research... and other collaborators

Unknown

Host Response Mediators in Coronavirus (COVID-19) Infection (ARBS CORONA I)

COVID-19 | SARS-CoV2

Canada
Shanghai Mental Health Center

Completed

Develop a Psychosis Risk Calculator for Chinese Mental Health Servises

Clinical High-risk

China
Washington University School of Medicine
Novartis Pharmaceuticals

Terminated

Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation

Kidney Transplant Rejection | Gastrointestinal Disorder, Functional

United States
Hakeam Abdulaziz Hakeam
King Khalid University Hospital; Princess Nourah Bint Abdulrahman University; Buraidah Central Hospital

Completed

Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives

COVID-19

Saudi Arabia
University of Campania "Luigi Vanvitelli"

Completed

Nephropathy In Type 2 Diabetes and Cardio-renal Events (NID-2)

Diabetic Nephropathy

Italy
NYU Langone Health

Terminated

Risk Factor Control Before Orthopedic Surgery (OPTMIZE-OS)

Cardiovascular Disease | Osteoarthritis

United States
Cairo University

Unknown

Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression

Metabolic Syndrome | Kidney Insufficiency | Diabete Type 2

Egypt
Boehringer Ingelheim
Eli Lilly and Company

Completed

Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study

Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Canada
Aversi Clinic

Unknown

Prestilol(Perindopril+Bisoprolol) in Therapy of Patients With Atrial Fibrilation

Patient Participation

Georgia
D'Or Institute for Research and Education
Brazilian Clinical Research Institute

Unknown

Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 (BRACE-CORONA)

COVID-19 | Corona Virus Infection

Brazil
XuanwuH 2
Xuanwu Hospital, Beijing

Completed

Multi-modality MRI Study on Differences in Conversion of aMCI Patients With APOEε4 to AD

Mild Cognitive Impairment

China
National University of Ireland, Galway, Ireland

Suspended

Coronavirus (COVID-19) ACEi/ARB Investigation (CORONACION)

COVID-19 | Hypertension

Ireland
Centers for Disease Control and Prevention, China
Shandong Province Centers for Disease Control and Prevention

Completed

Sero-conversion Study for a Two-dose Schedule of Sabin IPV in China

Poliomyelitis

China
Institut fuer anwendungsorientierte Forschung und...
German Federal Ministry of Education and Research; University Medical Center...

Completed

Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome

Renal Insufficiency, Chronic

Germany
Nisantasi University

Completed

Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019) (Covid-19)

Covid-19

Turkey
Velico Medical

Completed

Safety Study of ECO Conversion System For Red Blood Cells.

Anemia

United States
Institute of Cardiology, Warsaw, Poland

Unknown

Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19 (COR-CARDIO)

Cardiovascular Diseases | Hypertension | COVID | Cardiovascular Risk Factor

Poland
Versailles Hospital
Bernard LIVAREK, MD, Cardiology department, Versailles Hospital; Jean-Paul... and other collaborators

Unknown

Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19 (COVHYP)

COVID-19
First Affiliated Hospital Xi'an Jiaotong University

Completed

The Standardized Management of Hypertension in Rural Shaanxi

Hypertension

China
Assistance Publique - Hôpitaux de Paris

Unknown

Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID) (CAPTOCOVID)

COVID-19 | Coronavirus Infection | Pneumonia

France
National Institute of Diabetes and Digestive and...
The Cleveland Clinic

Completed

African American Study of Kidney Disease and Hypertension (AASK)

Hypertensive Nephrosclerosis | Chronic Renal Insufficiency
Assistance Publique - Hôpitaux de Paris
GIS EPI-PHARE

Unknown

Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse (TRAPSAH)

AMD, ACEi's/ARB Prevent/Worsen Risk of COVID-19 Infection

France
National Institute of Diabetes and Digestive and...
Washington University School of Medicine; Merck Sharp & Dohme LLC; University... and other collaborators

Completed

HALT Progression of Polycystic Kidney Disease Study B (HALT PKD B)

Kidney, Polycystic

United States
Nahla H Tohami

Unknown

Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

Diabetic Nephropathies

Egypt
National Institute of Diabetes and Digestive and...
Washington University School of Medicine; Merck Sharp & Dohme LLC; University... and other collaborators

Completed

HALT Progression of Polycystic Kidney Disease Study A (HALT PKD A)

Kidney, Polycystic

United States
RenJi Hospital

Unknown

Early Treatment of ARNI on Myocardial Remodeling and Progress

Myocardial Infarction

China
Hospital Universitari de Bellvitge

Completed

Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day. (TACPKPD)

Kidney Transplant; Complications

Spain
University of Edinburgh
NHS Lothian

Completed

BLB Study Back or Leg Pain and Bladder Symptoms Study (BLB)

Cauda Equina Syndrome | Functional Neurological Disorder

United Kingdom
University of Athens

Unknown

Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation

Cardiotoxicity | Hematopoietic Stem Cell Transplantation

Greece
Sun Yat-sen University

Completed

FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer (FOCULM)

Metastatic Colorectal Cancer

China
University College, London

Completed

The Pathophysiology of Functional Neurological Disorders

Functional Neurological Disorders

United Kingdom
Boryung Pharmaceutical Co., Ltd

Completed

Fimasartan in the Senior Subjects (FITNESS)

The Elderly (≥ 70 Years) With Essential Hypertension

Korea, Republic of
The First Affiliated Hospital of Guangzhou Medical...

Withdrawn

Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19

COVID-19

China
Yerevan State Medical University
Servier

Unknown

Effect of Atorvastatin on Carotid Intima Media Thickness

Hypercholesterolemia | Essential Hypertension
Ain Shams University

Unknown

Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma

Infantile Hemangioma

Egypt
Forest Laboratories

Completed

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

Hypertension

United States
Nanjing Children's Hospital

Unknown

The Research of Standard Diagnosis and Treatment for HSPN in Children

Henoch-Schoenlein Purpura Nephritis

China
Montreal Heart Institute
Servier

Completed

Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension (CTAF-2)

Atrial Fibrillation | Essential Hypertension

Canada
Chengdu University of Traditional Chinese Medicine

Completed

Acupoint Application in Patients With Stable Angina Pectoris (AASAP) (AASAP)

Stable Angina Pectoris

China
Novo Nordisk A/S

Completed

A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects

Healthy | Diabetes

Germany
Brigham and Women's Hospital
Novartis

Terminated

Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan) (PARENT)

Congestive Heart Failure

United States

Search clinical trials for: Conversion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations